Haemophilia

2.6(top 20%)

impact factor

5.6K(top 5%)

papers

115.0K(top 5%)

citations

110(top 5%)

h-index

2.7(top 20%)

impact factor

6.6K

all documents

120.4K

doc citations

160(top 5%)

g-index

Top Articles

#	Title	Journal	Year	Citations
1	Guidelines for the management of hemophilia	Haemophilia	2013	1,538
2	WFH Guidelines for the Management of Hemophilia, 3rd edition	Haemophilia	2020	915
3	von Willebrand disease (VWD): evidence‐based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA)¹	Haemophilia	2008	815
4	The epidemiology of inhibitors in haemophilia A: a systematic review	Haemophilia	2003	538
5	The rare coagulation disorders - review with guidelines for management from the United Kingdom Haemophilia Centre Doctors' Organisation	Haemophilia	2004	516
6	Inherited antithrombin deficiency: a review	Haemophilia	2008	325
7	Range of motion measurements: reference values and a database for comparison studies	Haemophilia	2011	293
8	Hemophilia joint health score reliability study	Haemophilia	2006	273
9	The obstetric and gynaecological management of women with inherited bleeding disorders - review with guidelines produced by a taskforce of UK Haemophilia Centre Doctors' Organization	Haemophilia	2006	267
10	Optimizing outcomes for patients with severe haemophilia A	Haemophilia	2007	235
11	Pathogenesis of haemophilic arthropathy	Haemophilia	2006	233
12	Normal range of bleeding scores for the ISTH‐BAT: adult and pediatric data from the merging project	Haemophilia	2014	230
13	Genetic risk factors for inhibitors to factors VIII and IX	Haemophilia	2006	229
14	International workshop on immune tolerance induction: consensus recommendations	Haemophilia	2007	228
15	Variant CJD infection in the spleen of a neurologically asymptomatic UK adult patient with haemophilia	Haemophilia	2010	226
16	A study of variations in the reported haemophilia A prevalence around the world	Haemophilia	2010	224
17	Rare coagulation deficiencies	Haemophilia	2002	215
18	Clinical severity of haemophilia A: does the classification of the 1950s still stand?	Haemophilia	2011	212
19	Safety of factor VIII inhibitor bypass activity (FEIBA® ): 10-year compilation of thrombotic adverse events	Haemophilia	2002	206
20	Guideline on the selection and use of therapeutic products to treat haemophilia and other hereditary bleeding disorders	Haemophilia	2008	206
21	Barriers to compliance with prophylaxis therapy in haemophilia	Haemophilia	2001	203
22	A randomized, double-blind comparison of two dosage levels of recombinant factor VIIa in the treatment of joint, muscle and mucocutaneous haemorrhages in persons with haemophilia A and B, with and without inhibitors	Haemophilia	1998	201
23	Rare inherited disorders of fibrinogen	Haemophilia	2008	197
24	Clinical diagnosis of von Willebrand disease	Haemophilia	2004	196
25	The Malmö International Brother Study (MIBS): further support for genetic predisposition to inhibitor development	Haemophilia	2001	193
26	Venous access in haemophilic children: choice and management	Haemophilia	2010	193
27	European Study on Orthopaedic Status of haemophilia patients with inhibitors	Haemophilia	2007	192
28	European principles of haemophilia care	Haemophilia	2008	191
29	Incidence of inhibitors in haemophilia A patients - a review of recent studies of recombinant and plasma-derived factor VIII concentrates	Haemophilia	1999	190
30	Consensus perspectives on prophylactic therapy for haemophilia: summary statement	Haemophilia	2003	190
31	Nanofiltration of plasma-derived biopharmaceutical products	Haemophilia	2003	185
32	Factor XIII deficiency	Haemophilia	2008	184
33	Prophylactic versus on-demand treatment strategies for severe haemophilia: a comparison of costs and long-term outcome	Haemophilia	2002	182
34	Gynaecological and obstetrical morbidity in women with type I von Willebrand disease: results of a patient survey	Haemophilia	2000	179
35	Analysis of low frequency bleeding data: the association of joint bleeds according to baseline FVIII activity levels	Haemophilia	2011	174
36	Pregnancy complications and obstetric care in women with inherited bleeding disorders	Haemophilia	2013	173
37	Assessing health-related quality-of-life in individuals with haemophilia	Haemophilia	1999	171
38	Implications of coagulation factor VIII and IX pharmacokinetics in the prophylactic treatment of haemophilia	Haemophilia	2011	170
39	Variable bleeding manifestations characterize different types of surgery in patients with severe factor XI deficiency enabling parsimonious use of replacement therapy	Haemophilia	2006	169
40	Protein C deficiency	Haemophilia	2008	169
41	Quality-of-life differences between prophylactic and on-demand factor replacement therapy in European haemophilia patients	Haemophilia	2002	168
42	More than menorrhagia: a review of the obstetric and gynaecological manifestations of bleeding disorders	Haemophilia	2005	166
43	The safety and efficacy of B-domain deleted recombinant factor VIII concentrate in patients with severe haemophilia A	Haemophilia	2003	165
44	FEIBAR: mode of action	Haemophilia	2004	165
45	The diagnosis of von Willebrand disease: a guideline from the UK Haemophilia Centre Doctors' Organization	Haemophilia	2004	164
46	Dose effect and efficacy of rFVIIa in the treatment of haemophilia patients with inhibitors: analysis from the Hemophilia and Thrombosis Research Society Registry	Haemophilia	2005	163
47	Early factor VIII exposure and subsequent inhibitor development in children with severe haemophilia A	Haemophilia	2007	160
48	Pharmacokinetics of activated recombinant coagulation factor VII (NovoSevenR) in children vs. adults with haemophilia A	Haemophilia	2004	158
49	Development and testing of an instrument to assess the Quality of Life of Children with Haemophilia in Europe (Haemo-QoL)	Haemophilia	2004	157
50	Factor X deficiency: clinical manifestation of 102 subjects from Europe and Latin America with mutations in the factor 10 gene	Haemophilia	2006	157

Scientometrics

Overviews

Citing Bodies

Haemophilia

Top Articles